Rifampicin and dexamethasone have similar effects on macrophage phagocytosis of zymosan, but differ in their effects on nitrite and TNF-α production

International Immunopharmacology

Volumn 3, Issue 4, 2003, Pages 513-522

  Mlambo, Godfree ^a   Sigola, Lynette B ^a  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

Dexamethasone; Macrophage; Nitric oxide; Phagocytosis; Rifampicin; Tumour necrosis factor alpha

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR ANTAGONIST; MIFEPRISTONE; NITRIC OXIDE; NITRITE; RIFAMPICIN; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG INHIBITION; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MALE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; SPLEEN CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELLS, CULTURED; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNITY, NATURAL; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; MIFEPRISTONE; NITRIC OXIDE; PHAGOCYTOSIS; RIFAMPIN; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA; ZYMOSAN;

EID: 0037388624     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00022-5     Document Type: Article

References (28)

1. Raviglione M.C., Snider D.E. Jr., Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA. 273:1995;220-226.
2. Stahl P.D., Ezekowitz R.A. The mannose receptor is a pattern recognition receptor involved in host defense. Curr. Opin. Immunol. 10:1998;50-55.
3. Dalton D.K., Pitts-Meek S., Keshav S., Figari I.S., Bradley A., Stewart T.A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 259:1993;1739-1742.
4. MacMicking J.D., North R.J., LaCourse R., Mudgett J.S., Shah S.K., Nathan C.F. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 94:1997;5243-5248.
5. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:1997;323-350.
6. Kindler V., Sappino A.P., Grau G.E., Piguet P.F., Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell. 56:1989;731-740.
7. Doherty G.M., Jensen J.C., Buresh C.M., Norton J.A. Hormonal regulation of inflammatory cell cytokine transcript and bioactivity production in response to endotoxin. Cytokine. 4:1992;55-62.
8. John M., Lim S., Seybold J., Jose P., Robichaud A.et al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am. J. Respir. Crit. Care Med. 157:1998;256-262.
9. Visser J., van Boxel-Dezaire A., Methorst D., Brunt T., de Kloet E.R., Nagelkerken L. Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro. Blood. 91:1998;4255-4264.
10. Di Rosa M., Radomski M., Carnuccio R., Moncada S. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem. Biophys. Res. Commun. 172:1990;1246-1252.
11. Zetterlund A., Larsson P.H., Muller-Suur C., Palmberg L., Larsson K. Budesonide but not terbutaline decreases phagocytosis in alveolar macrophages. Respir. Med. 92:1998;162-166.
12. Rabussay D., Zillig W. A rifampicin resistant RNA-polymerase from E. coli altered in the beta-subunit. FEBS Lett. 5:1969;104-106.
13. Calleja C., Pascussi J.M., Mani J.C., Maurel P., Vilarem M.J. The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor. Nat. Med. 4:1998;92-96.
14. Kenny M.T., Torney H.L., Balistreri F.J. Comparative effect of the naphthalenic ansamycins rifamycin SV, rifampin and cyclopentylrifampicin on murine neutrophil function. Int. J. Immunopharmacol. 11:1989;915-920.
15. Demkow U., Radomska D., Chorostowska-Wynimko J., Skopinska-Rozewska E. The influence of rifampicin on selected parameters of immunologic response. Pneumonol. Alergol. Pol. 66:1998;45-53.
16. 15N]nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
17. Cross C.E., Collins H.L., Bancroft G.J. CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans. Immunology. 91:1997;289-296.
18. Barnes P.J., Pedersen S., Busse W. Efficacy and safety of inhaled corticosteroids. Am. J. Respir. Crit. Care Med. 157:1998;S1-S53.
19. Bloom B.R., Murray C.J. Tuberculosis: commentary on a re-emergent killer. Science. 257:1992;1055-1064.
20. Riley L.W. Drug-resistant tuberculosis. Clin. Infect. Dis. 17:1993;S442-S446.
21. Alzeer A.H., FitzGerald J.M. Corticosteroids and tuberculosis: risks and use as adjunct therapy. Tuber. Lung Dis. 74:1993;6-11.
22. Bowman G., Malmborg A. Rifampicin in plasma and pleural fluid after single oral doses. Eur. J. Clin. Pharmacol. 7:1974;51-58.
23. Belayat F., Meniai K., Michaux C., Kafidi N., Coignoul F., Dewaele A. In vitro effect of glucocorticoids on phagocytic function of sheep alveolar macrophages. Vet. J. 155:1998;177-181.
24. Radomski M.W., Palmer R.M., Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 87:1990;10043-10047.
25. Kutteh W.H., Rainey W.E., Carr B.R. Glucocorticoids inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by human fetal Kupffer cells. J. Clin. Endocrinol. Metab. 73:1991;296-301.
26. Herr A.S., Wochnik G.M., Rosenhagen M.C., Holsboer F., Rein T. Rifampicin is not an activator of glucocorticoid receptor. Mol. Pharmacol. 57:2000;732-737.
27. Jaffuel D., Demoly P., Gougat C., Mautino G., Bousquet J., Mathieu M. Rifampicin is not an activator of the glucocorticoid receptor in A549 human alveolar cells. Mol. Pharmacol. 55:1999;841-846.
28. Tentori L., Graziani G., Porcelli S.A., Sugita M., Brenner M.B.et al. Rifampin increases cytokine-induced expression of the CD1b molecule in human peripheral blood monocytes. Antimicrob. Agents Chemother. 42:1998;550-554.